Divis Laboratories Ltd reported 7.29B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
Aurobindo Pharma INR 16.03B 1.89B Jun/2025
Avita Medical AUD -9863000 3.95M Dec/2024
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Divis Laboratories Ltd 7.29B 2.43B Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Lupin INR 17.27B 4.35B Jun/2025
Moderna USD -760000000 164M Jun/2025
Organon & Co USD 522M 114M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Tectonic Therapeutic USD -13483000 5.73M Dec/2024
Tilray USD -101000 2.32M Nov/2024
Viatris USD 1.08B 218.1M Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025